Antidiabetic effect of propolis: Reduction of expression of glucose-6-phosphatase through inhibition of Y279 and Y216 autophosphorylation of GSK-3α/β in HepG2 cells

Phytotherapy Research

Volumn 24, Issue 10, 2010, Pages 1554-1561

  Kang, Li Jung ^a   Lee, Hwanghee Blaise ^a   Bae, Hyeun Jong ^a   Lee, Seong Gene ^a  

^a Chonnam National University   (South Korea)

Author keywords

antidiabetes; antioxidant; G6Pase; GSK3; LY294002; phosphorylation; propolis

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; ACETYLCYSTEINE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HYDROGEN PEROXIDE; PROPOLIS; SERINE;

ANTIOXIDANT ACTIVITY; ARTICLE; AUTOPHOSPHORYLATION; CELL STRAIN HEPG2; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; Y216 GENE; Y279 GENE;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; BEES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; GLUCOSE-6-PHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3; HEP G2 CELLS; HUMANS; HYDROGEN PEROXIDE; HYPOGLYCEMIC AGENTS; LIPID PEROXIDATION; PHOSPHORYLATION; PROPOLIS;

APIS MELLIFERA;

EID: 78649425872     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3147     Document Type: Article

References (33)

1. Alessi DR, Downes CP., 1998. The role of PI 3-kinase in insulin action. Biochim Biophys Acta 1436: 151-164.
2. American Diabetes Association. 2000. Type 2 diabetes in children and adolescents (consensus statement). Diabetes Care 23: 381-389.
3. Aoki K, Saito T, Satoh S, et al,. 1999. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone. Diabetes 48: 1579-1585.
4. Banskota AH, Tezuka Y, Kadota S., 2001. Recent progress in pharmacological research of propolis. Phytother Res 15: 561-571.
5. Baynes JW, Thorpe SR., 1999. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9.
6. Burdock GA., 1998. Review of the biological properties and toxicity of bee propolis (propolis). Food Chem Toxicol 36: 347-363.
7. Castaldo S, Capasso F., 2002. Propolis, an old remedy used in modern medicine. Fitoterapia 73: S1-S6.
8. Celik S, Erdogan S., 2008. Caffeic acid phenethyl ester (CAPE) protects brain against oxidative stress and inflammation induced by diabetes in rats. Mol Cell Biochem 312: 39-46.
9. Cole A, Frame S, Cohen P., 2004. Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem J 377: 249-255.
10. Cross D, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA., 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-788.
11. Dembinska-Kiec A, Mykkänen O, Kiec-Wilk B, Mykkänen H., 2008. Antioxidant phytochemicals against type 2 diabetes. Br J Nutr 99: ES109-ES117.
12. Dickens M, Svitek CA, Culbert AA, O'Brien RM, Tavaré JM., 1998. Central role for phosphatidylinositide 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. J Biol Chem 273: 20144-20149.
13. Franzini L, Ardigo D, Zavaroni I., 2008. Dietary antioxidants and glucose metabolism. Curr Opin Clin Nutr 11: 471-479.
14. Fuliang HU, Hepburn HR, Xuan H, Chen M, Daya S, Radloff SE., 2005. Effects of propolis on blood glucose, blood lipid and free radicals in rats with diabetes mellitus. Pharmacol Res 51: 147-152.
15. Gierow P, Jergil B., 1982. Spectrophotometric method for glucose-6-phosphate phosphatase. Method Enzymol 89: 44-47.
16. Henriksen EJ, Dokken BB., 2006. Role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes. Curr Drug Targets 7: 1435-1441.
17. Hsu LY, Lin CF, Hsu WC, Hsu WL, Chang TC., 2005. Evaluation of polyphenolic acid esters as potential antioxidants. Biol Pharm Bull 28: 1211-1215.
18. Lee J, Kim M., 2007. The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract 77 (Suppl 1): S49-S57.
19. Li WL, Zheng HC, Bukuru J, Kimpe N., 2004. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 92: 1-21.
20. Liu JP, Zhang M, Wang W, Grimsgaard S., 2004. Chinese herbal medicines for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews CD003642.
21. Lochhead PA, Kinstrie R, Sibbet G, Rawjee T, Morrice N, Cleghon V., 2006. A chaperone-dependent GSK3 transitional intermediate mediates activation-loop autophosphorylation. Mol Cell 24: 627-633.
22. McLennan SV, Bonner J, Milne S, et al,. 2008. The anti-inflammatory agent propolis improves wound healing in a rodent model of experimental diabetes. Wound Repair Regen 16: 706-713.
23. Middleton M, Kandaswami C, Theoharides C., 2000. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52: 673-751.
24. Murata K, Yatsunami K, Fukuda E, et al,. 2004. Antihyperglycemic effects of propolis mixed with mulberry leaf extract on patients with type 2 diabetes. Altern Ther Health Med 10: 78-79.
25. Okutan H, Ozcelik N, Yilmaz R, Uz E., 2005. Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart. Clin Biochem 38: 191-196.
26. Polidori MC, Mecocci P, Stahl W, Eichler O, Niestroj I, Sies H., 2001. Profiles of antioxidants in human plasma. Free Radic Biol Med 30: 456-462.
27. Prasad RC, Herzog B, Boone B, Sims L, Waltner-Law M., 2005. An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes. J Ethnopharmacol 96: 295-301.
28. Rathmann W, Giani G., 2004. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 2568-2569.
29. Ring DB, Johnson KW, Henriksen EJ, et al,. 2003. Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo. Diabetes 52: 588-595.
30. Saltiel AR, Kahn R., 2001. Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414: 799-805.
31. UK Prospective Diabetes Study (UKPDS) Group. 1998. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-865.
32. Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, Granner DK., 2002. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. J Biol Chem 277: 34933-34940.
33. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N., 2004. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol 18: 234-238.